Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wunderlich

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.
Science (New York, N.Y.)|October 31, 2015
Immunogenicity of somatic mutations in human gastrointestinal cancersEric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2018
T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian CancersDrew C Deniger, Anna Pasetto, Paul F Robbins, et al.
The Journal of Investigative Dermatology|November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biologyZoltan Pos, Tara L Spivey, Hui Liu, et al.
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.
Science (New York, N.Y.)|October 31, 2015
Immunogenicity of somatic mutations in human gastrointestinal cancersEric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2018
T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian CancersDrew C Deniger, Anna Pasetto, Paul F Robbins, et al.
The Journal of Investigative Dermatology|November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biologyZoltan Pos, Tara L Spivey, Hui Liu, et al.
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
Pageof 15